These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16707546)

  • 1. Obesity and cardiovascular events in patients with established coronary disease.
    Domanski MJ; Jablonski KA; Rice MM; Fowler SE; Braunwald E;
    Eur Heart J; 2006 Jun; 27(12):1416-22. PubMed ID: 16707546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex difference in the effect of obesity on prognosis for patients undergoing percutaneous coronary intervention.
    Wang ZJ; Zhao YX; Liu YY; Shi DM; Gao F; Liu XL; Yu M; Zhou YJ
    Coron Artery Dis; 2012 Sep; 23(6):404-11. PubMed ID: 22828723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poststress left ventricular ejection fraction is an independent predictor of major cardiac events in patients with coronary artery disease and impaired left ventricular function.
    De Winter O; Van De Veire N; De Bondt P; Van De Wiele C; De Buyzere M; De Backer G; Gillebert TC; Dierckx RA; De Sutter J
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):296-304. PubMed ID: 17220816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index, coronary heart disease and stroke in Swedish women. A prospective 19-year follow-up in the BEDA study.
    Rosengren A; Wilhelmsen L; Lappas G; Johansson S
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):443-50. PubMed ID: 14671467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
    Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
    Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME; Remme WJ; Fox KM; Ferrari R; Simoons ML;
    Int J Cardiol; 2007 Sep; 121(1):57-61. PubMed ID: 17270296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for significant coronary artery disease in high-risk renal transplant candidates.
    Gowdak LH; de Paula FJ; César LA; Martinez Filho EE; Ianhez LE; Krieger EM; Ramires JA; de Lima JJ
    Coron Artery Dis; 2007 Nov; 18(7):553-8. PubMed ID: 17925609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
    Gazzaruso C; Solerte SB; Pujia A; Coppola A; Vezzoli M; Salvucci F; Valenti C; Giustina A; Garzaniti A
    J Am Coll Cardiol; 2008 May; 51(21):2040-4. PubMed ID: 18498958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity paradox in patients with hypertension and coronary artery disease.
    Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
    Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease.
    Romero-Corral A; Somers VK; Sierra-Johnson J; Jensen MD; Thomas RJ; Squires RW; Allison TG; Korinek J; Lopez-Jimenez F
    Eur Heart J; 2007 Sep; 28(17):2087-93. PubMed ID: 17626030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of Waist-Hip Ratio to Long-Term Cardiovascular Events in Patients With Coronary Artery Disease.
    Medina-Inojosa JR; Batsis JA; Supervia M; Somers VK; Thomas RJ; Jenkins S; Grimes C; Lopez-Jimenez F
    Am J Cardiol; 2018 Apr; 121(8):903-909. PubMed ID: 29482851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction.
    Buettner HJ; Mueller C; Gick M; Ferenc M; Allgeier J; Comberg T; Werner KD; Schindler C; Neumann FJ
    Eur Heart J; 2007 Jul; 28(14):1694-701. PubMed ID: 17576661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between anthropometric obesity measures and coronary artery disease: a cross-sectional survey of 16,657 subjects from 444 Polish cities.
    Kaess BM; Jozwiak J; Mastej M; Lukas W; Grzeszczak W; Windak A; Piwowarska W; Tykarski A; Konduracka E; Rygiel K; Manasar A; Samani NJ; Tomaszewski M
    Heart; 2010 Jan; 96(2):131-5. PubMed ID: 19651624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA;
    Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
    Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
    Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.